Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR
Öz
The neutrophil-to-lymphocyte ratio (NLR) and glucose-to-potassium ratio (GPR) are simple, readily available markers reflecting inflammatory and metabolic responses in acute stroke. However, their diagnostic value in emergency department (ED) presentations remains uncertain. This study evaluated the association of NLR and GPR with stroke among patients presenting with stroke-like symptoms. This retrospective study included 475 participants (286 stroke, 189 controls). Demographic, clinical, and laboratory data were analyzed. Independent predictors were identified using multivariable logistic regression, and diagnostic performance was assessed with receiver operating characteristic (ROC) analysis. Stroke patients were older than controls (59 vs. 43 years, p<0.001) and had higher prevalences of hypertension, diabetes mellitus, and coronary artery disease (all p<0.05). NLR, GPR, and C-reactive protein levels were higher (all p<0.001), while lymphocyte counts (p=0.015) and albumin levels (p=0.018) were lower. Age was an independent predictor of both ischemic and hemorrhagic stroke (p<0.001). GPR was independently associated with ischemic stroke (OR=1.08, 95% CI: 1.05–1.12, p<0.001). In hemorrhagic stroke, both NLR (OR=1.40, 95% CI: 1.20–1.65, p<0.001) and GPR (OR=1.13, 95% CI: 1.06–1.21, p<0.001) remained significant. Hypertension showed the strongest association with hemorrhagic stroke (p<0.001). ROC analysis demonstrated moderate discrimination (AUC: 0.636 for NLR; 0.729 for GPR). NLR and GPR were elevated in stroke and showed moderate diagnostic performance. GPR was associated with ischemic stroke, whereas both markers were linked to hemorrhagic stroke, suggesting complementary pathophysiological roles.
Anahtar Kelimeler
Destekleyen Kurum
Etik Beyan
Teşekkür
Kaynakça
- 1. Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120(3):439-48.
- 2. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439-58.
- 3. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612-23.
- 4. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743.
- 5. Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70. 6. Murphy SJ, Werring DJ. Stroke: causes and clinical features. Medicine (Abingdon). 2020;48(9):561-6.
- 7. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167-76.
- 8. Kelly PJ, Lemmens R, Tsivgoulis G. Inflammation and Stroke Risk: A New Target for Prevention. Stroke. 2021;52(8):2697-706.
- 9. Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007;38(2 Suppl):770-3.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Acil Tıp, Nöroloji ve Nöromüsküler Hastalıklar
Bölüm
Araştırma Makalesi
Yazarlar
Nazlı Kenan
*
0000-0002-0773-3384
Türkiye
Emine Doğan
0000-0002-8789-6705
Türkiye
Asiye Müminat Çap
0009-0000-9296-9502
Türkiye
Emine Kadıoğlu
0000-0003-0950-0477
Türkiye
Yavuz Yılmaz
0009-0009-9116-7570
Türkiye
Demet Acar
0009-0000-4748-4733
Türkiye
Yayımlanma Tarihi
12 Mayıs 2026
Gönderilme Tarihi
7 Ekim 2025
Kabul Tarihi
3 Mart 2026
Yayımlandığı Sayı
Yıl 2026 Cilt: 48 Sayı: 3